Markets:

Overview

News

Currencies

International

Treasuries

Privia Health Group, Inc. - Common Stock (NQ:PRVA)

20.02 -0.16 (-0.79%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Privia Health Group, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

1 Growth Stock with All-Star Potential and 2 We Find Risky

March 26, 2026

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...

Via StockStory

Healthcare Technology for Providers Stocks Q4 Recap: Benchmarking Astrana Health (NASDAQ:ASTH)

March 22, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare techno...

Via StockStory

Privia Health Group CFO Sells $283,000 Worth of Shares to Cover Taxes ↗

March 22, 2026

This healthcare company aims to provide high-value care for patients across the U.S. But is its stock a high-value investment?

Via The Motley Fool

Topics Regulatory Compliance

Privia Health Group Inc (NASDAQ:PRVA) Reports Mixed Q4 2025 Results, Beats on Profit but Misses on Revenue ↗

February 26, 2026

Via Chartmill

3 of Wall Street’s Favorite Stocks We Find Risky

March 20, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Via StockStory

Privia Health (PRVA): Buy, Sell, or Hold Post Q4 Earnings?

March 11, 2026

Privia Health has been treading water for the past six months, recording a small loss of 1.6% while holding steady at $22.55. Is there a buying opportunity i...

Via StockStory

Topics Artificial Intelligence Supply Chain

BlackBarn Capital Builds Warby Parker Stake as the Direct-to-Consumer Eyewear Leader Expands Nationwide ↗

March 04, 2026

BlackBarn Capital has raised its investment in Warby Parker, a direct-to-consumer eyewear brand recognized for its affordable frames and expanding network of stores. As Warby Parker opens more...

Via The Motley Fool

Topics Regulatory Compliance

Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

March 03, 2026

From Amalgam Rx, Inc.

Via Business Wire

Privia Health, Repligen, and RadNet Shares Plummet, What You Need To Know

February 27, 2026

A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures.

Via StockStory

Topics Economy Stocks

Privia Health (PRVA) Q4 2025 Earnings Transcript ↗

February 26, 2026

Privia Health (PRVA) Q4 2025 Earnings Transcript

Via The Motley Fool

Topics Artificial Intelligence

Privia Health (NASDAQ:PRVA) Reports Strong Q4 CY2025

February 26, 2026

Healthcare tech company Privia Health Group (NASDAQ:PRVA) announced better-than-expected revenue in Q4 CY2025, with sales up 17.4% year on year to $541.2 million. The company’s full-year revenue...

Via StockStory

Privia Health (PRVA) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 25, 2026

Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be announcing earnings results tomorrow before market open. Here’s what to expect.

Via StockStory

Acadia Healthcare, Hims & Hers Health, RadNet, Halozyme Therapeutics, and Privia Health Shares Are Soaring, What You Need To Know

February 13, 2026

A number of stocks jumped in the afternoon session after a softer-than-expected inflation report fueled hopes for interest rate cuts by the Federal Reserve. The January Consumer Price Index (CPI), a...

Via StockStory

Topics Economy

2 Small-Cap Stocks to Target This Week and 1 Facing Challenges

February 11, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

3 Cash-Producing Stocks Walking a Fine Line

February 08, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

1 Profitable Stock for Long-Term Investors and 2 We Avoid

February 05, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

Healthcare Technology for Providers Stocks Q3 Recap: Benchmarking Astrana Health (NASDAQ:ASTH)

February 02, 2026

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare technology for providers industry, including Astrana Health (NASDAQ:ASTH) and its peers.

Via StockStory

Healthcare Technology for Providers Stocks Q3 Highlights: Omnicell (NASDAQ:OMCL)

February 01, 2026

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Omnicell (NASDAQ:OMCL) and...

Via StockStory

3 Low-Volatility Stocks with Open Questions

January 28, 2026

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

Why Privia Health (PRVA) Shares Are Plunging Today

January 27, 2026

Shares of healthcare tech company Privia Health Group (NASDAQ:PRVA) fell 6.5% in the morning session after concerns swept the healthcare provider sector as industry giant UnitedHealth Group warned of...

Via StockStory

Topics Initial Public Offering

1 Growth Stock Set to Flourishand 2 That Underwhelm

January 26, 2026

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

Via StockStory

Topics Artificial Intelligence

Q3 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks

January 25, 2026

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including GoodRx (NASDAQ:GDRX) and its peers.

Via StockStory

2 Healthcare Stocks to Keep an Eye On and 1 We Ignore

January 12, 2026

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only...

Via StockStory

Topics Stocks

1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 We Avoid

December 31, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

What's going on in today's pre-market session ↗

December 29, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

Unpacking Q3 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks

December 18, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology stocks fared in Q3, starting with...

Via StockStory

1 Cash-Heavy Stock for Long-Term Investors and 2 We Turn Down

December 14, 2025

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Via StockStory

3 Reasons to Sell PRVA and 1 Stock to Buy Instead

December 11, 2025

Privia Health has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.6% to $24.88 per share while the index has gained...

Via StockStory

Topics Stocks Supply Chain

1 Cash-Producing Stock to Target This Week and 2 Facing Challenges

December 10, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

1 Safe-and-Steady Stock to Target This Week and 2 We Find Risky

December 07, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

Topics Bonds

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.